Narrow Results Clear All
- Communication Improvement 12
- Education and Training 5
- Error Reporting and Analysis 3
- Human Factors Engineering 1
- Quality Improvement Strategies 4
- Technologic Approaches 6
Search results for "Physicians"
Journal Article > Review
Consumer mobile apps for potential drug–drug interaction check: systematic review and content analysis using the Mobile App Rating Scale (MARS).
Kim BY, Sharafoddini A, Tran N, Wen EY, Lee J. JMIR Mhealth Uhealth. 2018;6:e74.
Patients are powerful allies in improving medication safety. This study found that available mobile applications that enable patients to check for drug–drug interactions are of moderate quality and low cost. They did not assess efficacy. An Annual Perspective examined other technological innovations for engaging patients in safety.
Journal Article > Study
Monkman H, Kushniruk AW. Stud Health Technol Inform. 2017;234:233-237.
Medication management in outpatient settings requires patients to recognize adverse medication effects. This expert review study found that standardized information from a large Canadian retail pharmacy lacked key information about possible adverse effects and drug interactions. The authors suggest that this information gap leads to an urgent and addressable patient safety risk.
Audiovisual > Audiovisual Presentation
Spiesel S, Chadwick A. "Day to Day." National Public Radio. August 27, 2008.
This radio program discusses the results of a study on the risk of fatal medication errors involving prescribed medications taken at home.
FDA Public Health Advisory. Silver Spring, MD: US Food and Drug Administration; December 21, 2007.
This Food and Drug Administration public health advisory alerts health care professionals, patients, and their caregivers to the possibility for overdoses of fentanyl in patients using fentanyl skin patches for pain control.
Web Resource > Multi-use Website
American Academy of Family Physicians, BlueCross BlueShield Association, Intel Corporation, Humana, Inc., Medical Group Management Association, and SureScripts, Inc., Alexandria, VA.
This center supports projects and research to promote safe medication management processes and effective technologies.
Cohen R. Star-Ledger. August 12, 2007;Business section:1.
This article describes how electronic prescribing can help reduce miscommunication and improve safety, although its universal adoption faces numerous barriers.
Journal Article > Commentary
Pollock M, Bazaldua OV, Dobbie AE. Am Fam Physician. 2007;75:231-236, 239-240.
The authors expand on an internationally recognized process for good prescribing by suggesting additional steps—considering drug costs and using technology to minimize medication error.
Brody JE. New York Times. January 2, 2007:F7.
This article discusses some common medication errors that consumers can avoid by asking the right questions and being familiar with prescriptions and the proper directions for taking them.
Foreman J. Los Angeles Times. September 4, 2006:F3.
This article describes what patients can do to minimize opportunities for medication error.
Chun D. Gainsville Sun. August 21, 2006.
This article describes a computerized drug ordering and dispensing system at a Florida hospital.
Journal Article > Study
Diagramming patients' views of root causes of adverse drug events in ambulatory care: an online tool for planning education and research.
Brown M, Frost R, Ko Y, Woosley R. Patient Educ Couns. 2006;62:302-315.
Journal Article > Study
Sharif I, Lo S, Ozuah PO. J Health Care Poor Underserved. 2006;17:65-69.
The authors surveyed pharmacies in the Bronx, New York, and found that 69% could provide prescription labels in Spanish, and that most used a computer program to translate the labels.
Consumers Filling U.S. Prescriptions Abroad May Get the Wrong Active Ingredient Because of Confusing Drug Names.
FDA Public Health Advisory [US Food and Drug Administration Web site]. January 2006.
This U.S. Food and Drug Administration advisory alerts clinicians and consumers to potential mistakes in prescriptions purchased abroad. The advisory includes a table of medications known to contain different active ingredients when purchased outside the United States.
Franklin D. New York Times. October 25, 2005:F1.
This article discusses an important health literacy and medication safety concern: the absence of standardization of colored warning labels applied to prescription bottles. Inconsistent messages, icons, and colors may cause confusion for consumers.
Chase M. Wall Street Journal. August 16, 2005:D1.
This article reports that in other countries, some medications have the same brand name as U.S. medications but contain completely different ingredients, often for treatment of different conditions. To avoid mix-ups, the article cautions against purchasing prescription medications abroad.
Cohen B. "Morning Edition." National Public Radio. August 1, 2005.
This audio segment reports on a new prescription bottle that allows physicians and pharmacists to record verbal instructions, which patients can then retrieve by pushing a button on the bottle.
Rados C. FDA Consum. 2005;39:35-37.
This article reports on problems with drug names, the naming process for medications, and both industry and consumer actions that can minimize misunderstandings.
McNeil Consumer & Specialty Pharmaceuticals announces nationwide recall of Children's Tylenol Meltaways - 80 Mg, Children's Tylenol Softchews - 80 Mg and Jr. Tylenol Meltaways - 160 Mg [press release].
Fort Washington, PA: McNeil Consumer & Specialty Pharmaceuticals; June 3, 2005.
This news release announces the recall of several Tylenol children's medications. The packaging and labeling for these medications may be confusing and lead to overdosing.